Nasdaq tmdx.

TransMedics Group, Inc. 01 Mar, 2021, 16:15 ET. ANDOVER, Mass., March 1, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX ), a medical technology company that is ...TMDX NASDAQ. TMDX NASDAQ. TMDX NASDAQ. Market closed Market closed. No trades. See on Supercharts. Overview News Ideas Financials Technicals . Forecast . Price target. 79.20 0.00 0.00%. The 5 analysts offering 1 year price forecasts for TMDX have a max estimate of — and a min estimate of —.ANDOVER, Mass., Nov. 3, 2022 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...TransMedics Group (NASDAQ: TMDX) fool.com - August 19 at 11:22 PM: Spouting Rock Asset Management LLC Lowers Stake in TransMedics Group, Inc. (NASDAQ:TMDX) marketbeat.com - August 18 at 9:41 AM: TransMedics (TMDX) Acquires Summit Aviation for Organ Transplant finance.yahoo.com - August 17 at 6:32 PMEntering text into the input field will update the search result below

Back to TMDX Overview About Latest Pre-Market Trades Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following …The Weiss investment rating of TransMedics Group, Inc. (NASDAQ: TMDX) is D-.One such superstar is TransMedics Group, Inc. (NASDAQ:TMDX), which saw its share price soar 340% in three years. Also pleasing for shareholders was the 21% gain in the last three months.

TransMedics ( TMDX 3.88%), a newly public med-tech company, has invented a new organ transportation system that promises to bring the process into the 21st century. In this episode of Industry ...Transmedics Group Inc (NASDAQ:TMDX) trade information. Sporting 8.65% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Tuesday, 11/14/23 when the TMDX stock price touched $64.81 or saw a rise of 2.42%.

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today ...TransMedics Group Inc (Symbol: TMDX) saw options trading volume of 3,088 contracts, representing approximately 308,800 underlying shares or approximately 85.5% of TMDX's average daily trading ...ANDOVER, Mass., May 26, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients ...With revenue growth of 69% y/y in 2018 and a long list of institutional investors financing TransMedics Group (NASDAQ:TMDX), market participants should review the company’s technology.Having ...

Nike, Inc. has no single specific owner. According to Nasdaq, the company is a publicly traded one, with its shares listed on the New York Stock Exchange under the symbol NKE. As of May, 2014, 83.29 percent of Nike’s shares were owned by in...

In recent trading, shares of TransMedics Group Inc (Symbol: TMDX) have crossed above the average analyst 12-month target price of $78.60, changing hands for $79.05/share. When a stock reaches the ...

Aug 3, 2023 · ANDOVER, Mass., Aug. 3, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ... TransMedics Group (NASDAQ:TMDX) rallied 38.9%, reporting Q3 losses of $0.78 per share versus expected losses of $0.16 per share. Revenues came in at $66.4 million versus $49.19 million expected.Aug 7, 2023 · In trading on Monday, shares of TransMedics Group Inc (Symbol: TMDX) crossed below their 200 day moving average of $70.28, changing hands as low as $68.37 per share. TransMedics Group Inc shares ... TransMedics Group (NASDAQ:TMDX) provides organ preservation technology and is a leader in normothermic machine perfusion.Its FDA-approved Organ Care System replicates the body’s physiologic ...May 21, 2023 · COGS surged from $9 million in 2020 to $28.2 million in 2022, while operating expenses surged from $43 million in 2020 to $96.7 million in 2022. However, there's some good news in terms of the ...

A. The latest price target for TransMedics Gr ( NASDAQ: TMDX) was reported by JP Morgan on Tuesday, November 7, 2023. The analyst firm set a price target for 70.00 expecting TMDX to rise to within ...Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated therapeutics for the treatment of neurodegenerative and ...Sep 10, 2021 · We note that TransMedics Group, Inc. (NASDAQ:TMDX) does have debt on its balance sheet. But the real question is whether this debt is making the company risky. But the real question is whether ... Nov 24, 2023 · TransMedics Group, Inc. (NASDAQ:TMDX) posted its quarterly earnings data on Monday, November, 6th. The company reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.06. The business earned $66.43 million during the quarter, compared to analysts' expectations of $48.05 million. TransMedics (Nasdaq:TMDX) shares got a massive boost today on first-quarter sales that were 64% higher than the consensus forecast.. TMDX shares were up more than 30% at $28.44 apiece by midday ...

View live TransMedics Group, Inc. chart to track its stock's price action. Find market predictions, TMDX financials and market news.

NASDAQ: TransMedics Group Inc (TMDX) = 75.68 USD. Provided by Alpha Vantage. TransMedics Group Inc stock (TMDX) in USD. 1 TMDX = 75.68 USD. 1 month. 6 months. 1 year. 5 years. Hold over 40 currencies to convert and send money at any time. Abra uma conta. TransMedics Group Inc stock performance at a glance.Transmedics Group Inc (TMDX) shares have gone up 0.77% during the last six months, with a year-to-date growth rate more than the industry average at 18.70% against 10.30. Yet analysts are ramping up their growth forecast for the fiscal year 2023. Revenue is predicted to grow 90.50% this quarter and then drop -112.50% in the quarter after that.Nov 24, 2023 · A. The latest price target for TransMedics Gr ( NASDAQ: TMDX) was reported by JP Morgan on Tuesday, November 7, 2023. The analyst firm set a price target for 70.00 expecting TMDX to rise to within ... ANDOVER, Mass., Jan. 5, 2022 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...Sep 8, 2021 · Sep 8, 2021 11:17AM EDT. TransMedics Group, Inc. TMDX recently announced its receipt of the FDA’s premarket approval of its OCS Heart System for use with organs from donors after brain death ... Entering text into the input field will update the search result belowTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure ...

Transmedics Group Inc (NASDAQ:TMDX) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest ...

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and ...

Avid Technology, Inc. (NASDAQ:AVID) is the most popular stock in this table. On the other hand VirnetX Holding Corporation (NYSE: VHC ) is the least popular one with only 5 bullish hedge fund ...Sep 8, 2021 · Sep 8, 2021 11:17AM EDT. TransMedics Group, Inc. TMDX recently announced its receipt of the FDA’s premarket approval of its OCS Heart System for use with organs from donors after brain death ... TransMedics (TMDX) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.42 per share a year ago. These figures are ...ANDOVER, Mass., April 28, 2022 /PRNewswire/ -- TransMedics Group, Inc. (" TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval …ANDOVER, Mass., Feb. 23, 2022 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...TransMedics Group, Inc. 01 Mar, 2021, 16:15 ET. ANDOVER, Mass., March 1, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX ), a medical technology company that is ...Dec 1, 2023 · The list of insiders at TransMedics Group includes Abrams Capital Management, L.P, David Weill, Edward M Basile, Edwin M Kania Jr, James R Tobin, John F Carey, John F Sullivan, Laura Damme, Miriam Provost, Stephanie Lovell, Stephen Gordon, Tamer I Khayal, and Waleed H Hassanein. ANDOVER, Mass., Oct. 10, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...

Find the latest Insider Activity data for TransMedics Group, Inc. Common Stock (TMDX) at Nasdaq.com.Nov 6, 2023 · Net loss for the third quarter of 2023 was $25 .4 million, compared to $7.4 million in the third quarter of 2022. The increase in net loss was driven primarily by $29.2 million in non-recurring ... TherapeuticsMD, Inc. (NASDAQ:TXMD) announced its quarterly earnings data on Monday, August, 14th. The company reported ($0.24) earnings per share for the …Oct 18, 2023 · TMDX’s goal is to have 10-15 planes by operation in H1-24, and each plane typically costs $10-$12m (TMDX does not plan to lease the planes), so you could be potentially looking at capital costs ... Instagram:https://instagram. forex trading app downloadsupplemental dental insurance arizonao realty dividendpenny stocks below 10 cents With a market capitalization of US$477m, TransMedics Group is a small cap stock, so it might not be well known by many institutional investors. Taking a look at our data on the ownership groups ... investment for grandchildrenbest stocks for day traders Transmedics Group Inc (NASDAQ:TMDX) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest ... atlas energy solutions stock ANDOVER, Mass., May 06, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients ...Nov 24, 2023 · LivaNova (NASDAQ:LIVN) and TransMedics Group (NASDAQ:TMDX) are both mid-cap medical companies, but which is the superior business?We will compare the two companies based on the strength of their analyst recommendations, community ranking, profitability, institutional ownership, valuation, dividends, risk, media sentiment and earnings. COGS surged from $9 million in 2020 to $28.2 million in 2022, while operating expenses surged from $43 million in 2020 to $96.7 million in 2022. However, there's some good news in terms of the ...